Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Other Non-Current Liabilities (2021 - 2026)

Core Scientific has reported Other Non-Current Liabilities over the past 6 years, most recently at $100.6 million for Q1 2026.

  • Quarterly results put Other Non-Current Liabilities at $100.6 million for Q1 2026, up 811.51% from a year ago — trailing twelve months through Mar 2026 was $100.6 million (up 811.51% YoY), and the annual figure for FY2025 was $104.3 million, down 90.5%.
  • Other Non-Current Liabilities reached $100.6 million in Q1 2026 per CORZ's latest filing, down from $104.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.3 billion in Q3 2025 and bottomed at $2.2 million in Q4 2022.
  • Median Other Non-Current Liabilities over the past 5 years was $93.9 million (2023), compared with a mean of $328.9 million.
  • The largest annual shift saw Other Non-Current Liabilities skyrocketed 1672.0% in 2023 before it plummeted 98.84% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $2.2 million in 2022, then surged by 4146.74% to $93.9 million in 2023, then surged by 1069.15% to $1.1 billion in 2024, then crashed by 90.5% to $104.3 million in 2025, then fell by 3.46% to $100.6 million in 2026.
  • Business Quant data shows Other Non-Current Liabilities for CORZ at $100.6 million in Q1 2026, $104.3 million in Q4 2025, and $1.3 billion in Q3 2025.